Physician profile
Aaron E Mitschke
NPI 1831450063
$3,564.57
in general payments reported to CMS, 2019-2025
40 companies · $483 in 2025
The $483 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $898 · 2022: $748 · 2023: $738 · 2024: $698 · 2025: $483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,919.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,919.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $935.25 | 2021-2025 | |
| Lilly USA, LLC | $413.19 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Astrazeneca Pharmaceuticals LP | $295.95 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $278.97 | 2021-2025 | |
| Novo Nordisk INC | $259.32 | 2021-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $200.04 | 2021-2023 | Arexvy, Trelegy Ellipta |
| Otsuka America Pharmaceutical, INC. | $99.91 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $78.06 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $75.42 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $75.03 | 2022 | |
| Eisai INC. | $66.48 | 2021 | |
| Sumitomo Pharma America, INC. | $62.41 | 2023-2025 | Gemtesa |
| Biohaven Pharmaceuticals, INC. | $52.20 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.69 | 2021-2024 | Xifaxan |
| Abbott Laboratories | $44.19 | 2024-2025 | Freestyle Libre 3, Proclaim |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Mitschke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.